Methodological issues in AIDS clinical trials. Analysis and interpretation of trial results. Discussion.
Hauptman
L
L
Division of Biometrics, U.S. Food and Drug Administration, Rockville, Maryland.
Segreti
A
A
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D002986:Clinical Trials as Topic / Q000379:methods*; D006801:Humans; D016032:Randomized Controlled Trials as Topic / Q000379:methods